Get started
Author

Jordan Richards

Sequential Intravesical Gemcitabine and Docetaxel for bacillus Calmette-Guérin-Naïve High-Risk Nonmuscle-Invasive Bladder Cancer
2022 · Ian M. McElree, Ryan L. Steinberg, et al. · The Journal of Urology · 76
Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma
2022 · Josiah An, Vignesh T. Packiam, et al. · Frontiers in Oncology · 17
PDF
The current landscape of salvage therapies for patients with bacillus Calmette-Guérin unresponsive nonmuscle invasive bladder cancer
2021 · Vignesh T. Packiam, Jordan Richards, et al. · Current Opinion in Urology · 14
How the Beneficial Effects of Alvimopan Differ With Surgical Approach for Radical Cystectomy
2020 · Kassem S. Faraj, Nathanael Z. Judge, et al. · Urology · 3
Combined robotic radical prostatectomy and laparoscopic proctectomy for synchronous prostate and rectal cancer
2022 · Zachary Tully, Jordan Richards, et al. · Urology Case Reports · 2
PDF
Reply by Authors
2022 · Ian M. McElree, Ryan L. Steinberg, et al. · The Journal of Urology · 1
An Artificial Intelligence-powered Model to Predict Response to Intravesical Bcg Versus Gemcitabine-docetaxel for High-risk Non-muscle Invasive Bladder Cancer
2025 · Vignesh T. Packiam, Ian McElree, et al. · Urologic Oncology Seminars and Original Investigations
Long-term follow-up of intravesical gemcitabine and docetaxel as rescue therapy for nonmuscle-invasive bladder cancer.
2022 · Phani T. Chevuru, Ian Mitchell McElree, et al. · Journal of Clinical Oncology
Sequential intravesical gemcitabine and docetaxel for BCG-naïve high-risk nonmuscle-invasive bladder cancer.
2022 · Ian Mitchell McElree, Ryan L. Steinberg, et al. · Journal of Clinical Oncology
Mp61-03 Lymph Node Yield Variability After Radical Cystectomy: the Effect of Pathological Processing and Microscopic Examination
2020 · Kassem Faraj*, Nathanael Judge, et al. · The Journal of Urology
Works count: 10
Citation count: 113
H-index: 3
I10-index: 3
Year
Topic
Type